Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging pharmacotherapy for inflammatory bowel diseases
Hua Luo, Guiqing Cao, Chun Luo, et al.
Pharmacological Research (2022) Vol. 178, pp. 106146-106146
Closed Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Progressing advanced therapies for inflammatory bowel disease: Current status including dual biologic therapy and discontinuation of biologics
Kazuo Yashima, Hiroki Kurumi, Naoyuki Yamaguchi, et al.
Expert Review of Gastroenterology & Hepatology (2025)
Closed Access
Ginseng exosomes modulate M1/M2 polarisation by activating autophagy and target IKK/IкB/NF-кB to alleviate inflammatory bowel disease
Song Yang, Liangliang Fan, Lijia Yin, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Thymol Alleviates Colitis by Modulating Intestinal Barrier Damage, Gut Microbiota, and Amino Acid Metabolic Pathways
Ziwen Ma, Xin Wen, Yahan Zhang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access
3-Fucosyllactose alleviates DSS-induced mouse colitis through modulation of the PI3K-Akt signaling pathway: An integrated multi-omics analysis
Qian Hao, Xutong Li, Mingzhu Mu, et al.
Journal of Functional Foods (2025) Vol. 127, pp. 106789-106789
Open Access
Clinacanthus nutans restores the intestinal barrier in UC via regulatings oxidative stress to suppress the occurrence of ferroptosis
Ximin Wang, Qing Luo, Jing Yang, et al.
Journal of Functional Foods (2025) Vol. 129, pp. 106863-106863
Closed Access
Strategies and opportunities of micro/nano delivery systems for targeted therapy of ulcerative colitis: Focus on underlying mechanisms and future perspectives
Zihan Liu, Han Liu, Jialing Cheng, et al.
Chinese Chemical Letters (2023) Vol. 35, Iss. 2, pp. 109074-109074
Closed Access | Times Cited: 10
Experimental colitis-induced visceral hypersensitivity is attenuated by GABA treatment in mice
Michael S. Gold, Emanuel Loeza-Alcocer
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 3, pp. G252-G263
Closed Access | Times Cited: 3
Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway
Ju Huang, Jing Li, Zhijun Geng, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Exploring the potential mechanism of B-phycoerythrin on DSS-induced colitis and colitis-associated bone loss based on network pharmacology, molecular docking, and experimental validation
Lu-Ming Deng, Feng Zhang, Xingyan Li, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Orally administered hydrogel containing polyphenol@halloysite clay for probiotic delivery and treatment of inflammatory bowel disease
Xiangyu Chen, Yue Feng, Di Zhang, et al.
Nano Today (2025) Vol. 62, pp. 102669-102669
Closed Access
Ganoderic Acid Ameliorates Ulcerative Colitis by Improving Intestinal Barrier Function via Gut Microbiota Modulation
Yuwei Ye, Abudumijiti Abulizi, Yukun Zhang, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2466-2466
Open Access
Biosilicification-mimicking chiral nanostructures for targeted treatment of inflammatory bowel disease
Miao Xu, Wei Xin, Jiabin Xu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Oral Targeted MXenzyme – Armed Probiotic Regulates Intestinal Redox and Microbiota Homeostasis to Synergistically Ameliorate Ulcerative Colitis
Peng Li, Jueshuo Guo, Qiqi Zhang, et al.
Advanced Functional Materials (2025)
Closed Access
Oral pH- and inflammation-targeted delivery system with biodegradable multi-layer core–shell nanocapsules for the treatment of ulcerative colitis
Tianle Li, Jie Zhou, Jianyou Gu, et al.
Nanoscale (2025) Vol. 17, Iss. 16, pp. 10124-10141
Closed Access
Efficacy and safety of IL-23 p19 inhibitors in the treatment for inflammatory bowel disease: a systematic review and meta-analysis
Shuhan Wang, Hui Sun, Qian Wang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Protective effects of Nippostrongylus brasiliensis-derived uridine via the apical sodium-dependent bile acid transporter in a mouse model of TNBS-induced inflammatory bowel disease
Caiyi Yuan, Qiang Wang, Yuying Chen, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ligninoformic acid improved DSS-induced chronic colitis in mice by regulating intestinal flora and intestinal barrier
Hongtao Wang, Jiayi Weng, Issoufou Amadou, et al.
Microbial Pathogenesis (2025) Vol. 205, pp. 107670-107670
Closed Access
Disparities in Access and Treatment for Rural Patients With Inflammatory Bowel Disease: A Survey of Inflammatory Bowel Disease Patients and Providers
Timothy L. McAuliffe, Jessica K. Salwen‐Deremer, Corey A. Siegel
Inflammatory Bowel Diseases (2025)
Closed Access
Encouraging Tactics with Genetically Modified Probiotics to Improve Immunity for the Prevention of Immune-Related Diseases including Cardio-Metabolic Disorders
Tomoko Asai, Sayuri Yoshikawa, Yuka Ikeda, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 10-10
Open Access | Times Cited: 15
Discovery of a novel RIPK2 inhibitor for the treatment of inflammatory bowel disease
Yujun Lai, Xinhui Wang, Xue Sun, et al.
Biochemical Pharmacology (2023) Vol. 214, pp. 115647-115647
Open Access | Times Cited: 8
Crosstalk between hypoxia-inducible factor-1α and short-chain fatty acids in inflammatory bowel disease: key clues toward unraveling the mystery
Jinyin Xiao, Xiajun Guo, Zhenquan Wang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation
Yitao Ou, Zhongjin Yang, Yinghua Zhou, et al.
European Journal of Pharmacology (2024) Vol. 965, pp. 176331-176331
Closed Access | Times Cited: 2
Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis
Ranjit K. Harwansh, Hemant Bhati, Rohitas Deshmukh
Current Pharmaceutical Design (2024) Vol. 30, Iss. 6, pp. 420-439
Closed Access | Times Cited: 2
Bioinspired and biomimetic strategies for inflammatory bowel disease therapy
Limei Zhang, Ye Peng, Huatai Zhu, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 15, pp. 3614-3635
Closed Access | Times Cited: 2
Magnoflorine alleviates dextran sulfate sodium‐induced ulcerative colitis via inhibiting JAK2/STAT3 signaling pathway
Jianxia Wen, Yi Yang, Lu Li, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 9, pp. 4592-4613
Closed Access | Times Cited: 2

Scroll to top